Literature DB >> 92893

The inhibition of corneal vascularization with aortic extracts in rabbits.

R Eisenstein, S B Goren, B Shumacher, E Choromokos.   

Abstract

A low molecular weight fraction of bovine aortic extract inhibited corneal vascularization and edema in rabbits when administered either subconjunctivally or topically as long as 48 hours after injury. The extract also appeared to enhance the regression of newly formed corneal vessels. Topical administration for as long as two months had no deleterious ocular side effects. Tissue culture experiments showed that analagous fractions prepared from bovine vitreous inhibit endothelial cell growth. The major growth inhibitor of corneal neovascularization was not the Kunitz bovine protease inhibitor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92893     DOI: 10.1016/0002-9394(79)90406-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea.

Authors:  A Parke; P Bhattacherjee; R M Palmer; N R Lazarus
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2. 

Authors:  R Rochels
Journal:  Doc Ophthalmol       Date:  1984-05       Impact factor: 2.379

3.  Additive cytotoxicity of adriamycin and a naturally occurring growth inhibitor extracted from bovine aorta.

Authors:  M Haid; J Cohen; G Mazariegos; S Murthy; R Eisenstein; J D Travis
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

4.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-beta type 1.

Authors:  S Magyar-Lehmann; P Böhlen
Journal:  Experientia       Date:  1992-04-15

6.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone.

Authors:  J Gross; R G Azizkhan; C Biswas; R R Bruns; D S Hsieh; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.